Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519194 · ClinicalTrials.gov registry record · NA
CONcomitant eValuation of Epicor Left atRial Therapy for AF
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT00519194 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 112 participants.
The verdict
NCT00519194, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest and/or open heart surgery for one of more of the following procedures: mitral valve repair or replacement, aortic valve repair or replacement, tricuspid valve repair or replacement, coronary artery bypass surgery or patent foramen ovale (PFO closure).
Interventions
- DEVICE Epicor LP Cardiac Ablation System
- PROCEDURE Surgical ablation of permanent AF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00519194
The ClinicalTrials.gov registry entry for NCT00519194 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epicor LP Cardiac Ablation System is the first listed.
NCT00519194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00519194 about?
NCT00519194 is a clinical study titled "CONcomitant eValuation of Epicor Left atRial Therapy for AF". The purpose of this study is to test the safety and efficacy of the Epicor LP Cardiac Ablation System for treating permanent atrial fibrillation during concomitant open chest and/or open heart surgery for one of more of the following procedures: mitral valve repair or replacement, aortic valve repai...
What is the current status of trial NCT00519194?
This trial is currently terminated. It is a NA study. The enrollment target is 112 participants. The study started on 2009-04. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00519194?
The interventions under investigation include: Epicor LP Cardiac Ablation System (DEVICE), Surgical ablation of permanent AF (PROCEDURE).
Who is sponsoring clinical trial NCT00519194?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.